TP53
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Venetoclax and Decitabin Based Conditioning Regimen Followed With Post-HSCT Decitabin Maintenance Therapy in TP53 Mutant AML/MDS Patients (NCT05528354) | Zhejiang University | 2022-06-02 |
| Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT (NCT04123392) | Nanfang Hospital, Southern Medical University | 2019-10-01 |
Track TP53 automatically
Every clearance here is in the API, with alerts when new ones post.